drugset / Trial / NCT00444574
Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study designed to evaluate the safety and efficacy of MTS compared to placebo with reference to CONCERTA® in pediatric subjects diagnosed with ADHD.
Timeline
- Start
- 2004-09
- Primary completion
- 2005-06
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylphenidate | Small molecule | 2.7 mg | Other |
| Comparator | Methylphenidate | Small molecule | 10 mg | Other |
| Comparator | Methylphenidate | Small molecule | 15 mg | Other |
| Comparator | Methylphenidate | Small molecule | 18 mg | Other |
| Comparator | Methylphenidate | Small molecule | 20 mg | Other |
| Comparator | Methylphenidate | Small molecule | 27 mg | Other |
| Comparator | Methylphenidate | Small molecule | 30 mg | Other |
| Comparator | Methylphenidate | Small molecule | 36 mg | Other |
| Comparator | Methylphenidate | Small molecule | 41.3 mg | Other |
| Comparator | Methylphenidate | Small molecule | 54 mg | Other |
| Comparator | Methylphenidate | Small molecule | 55 mg | Other |
| Comparator | Methylphenidate | Small molecule | 82.5 mg | Other |